Participating Companies


Tricida, Inc. [TCDA] US$1,326 MM MCap
Tri­ci­da is a late-stage phar­ma­ceu­ti­cal com­pany fo­cused on the de­vel­op­ment and com­mer­cial­iza­tion of their drug can­di­date, TR­C101, a non-ab­sorbed po­ly­mer de­signed to treat metabolic aci­do­sis by bind­ing and re­mov­ing acid from the gas­troin­testi­nal tract, or GI tract. [more in­for­ma­tion]